483
Gemini PharmChem Mannheim GmbHGemini PharmChem Mannheim GmbH – FDA 483, Jan 21, 2022
Record Details
During an inspection of Gemini PharmChem Mannheim GmbH, an API drug manufacturer in Mannheim, Germany, the FDA observed three issues. These included the storage of secondary packaging components in a non-GMP area, a lack of documentation for incoming material inspection checklists, and incomplete records and reports, specifically regarding deviations and raw data sheets.
View Company Profile
ID · e1ed594e-3ac0-40ed-8645-862e8514d073
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.